Results 11 to 20 of about 10,579 (231)

Positive and negative AIT trials: What makes the difference? [PDF]

open access: yes, 2018
Background: Allergen immunotherapy has proven to be efficacious in allergic rhinitis and asthma. However, results from randomised clinical trials may vary substantially. Clinical trials may unexpectedly fail.
Gerth van Wijk, R. (Roy)
core   +10 more sources

The future outlook on allergen immunotherapy in children: 2018 and beyond. [PDF]

open access: yes, 2018
Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases.
Arasi S, Corsello G, Pajno GB, Villani A
core   +2 more sources

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis [PDF]

open access: yes, 2013
© Queen’s Printer and Controller of HMSO 2013Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing
Barton, P   +7 more
core   +1 more source

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma [PDF]

open access: yes, 2019
Background: Sublingual allergen immunotherapy (SLIT) has been demonstrated to be both clinically efficacious and safe. However, in line with the current regulatory guidance from the European Medicines Agency, allergen immunotherapy (AIT) products must ...
Bachert, Claus   +10 more
core   +2 more sources

Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs : a blind, randomized, placebo-controlled study [PDF]

open access: yes, 2017
Background: Food allergies are increasing in prevalence but no treatment strategies are currently available to cure dogs with food allergy. Over the past decade, experimental food allergen-specific sublingual immunotherapy (FA-SLIT) has emerged as a ...
Cox, Eric   +3 more
core   +2 more sources

The Effectiveness of Sublingual Allergen-Specific Immunotherapy in Children with Allergic Rhinitis

open access: yesZdorovʹe Rebenka, 2015
The article analyses the effectiveness of sublingual allergen-specific immunotherapy with sublingual house dust mite and pollen allergens (early and late spring and autumn grass mixture) in patients with seasonal allergic rhinitis, perennial allergic ...
M.P. Prokhorova
doaj   +1 more source

What's new in the diagnosis and management of food allergy in children? [PDF]

open access: yes, 2013
This article reviews the recent advances in the diagnosis and management of IgE mediated food allergy in children. It will encompass the emerging technology of component testing; moves to standardization of the allergy food challenge; permissive diets ...
Campbell, DE, Turner, PJ
core   +1 more source

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the "con" view. [PDF]

open access: yes, 2016
Atopic dermatitis (AD) is a common chronic skin condition in children that has a proven association with other atopic conditions and allergies. These associations, like the general pathophysiology of AD, are complex and not fully understood.
Eichenfield, Lawrence F   +1 more
core   +3 more sources

ASIT – A SOLUTION IN ALLERGY TREATMENT

open access: yesМедицинский совет, 2017
This article discusses the place and role of an allergen-specific immunotherapy in the treatment of allergic diseases. It provides an action mechanism, indications for use, contraindications, and side effects of an allergen-specific immunotherapy.
S. V. TSAREV
doaj   +1 more source

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years [PDF]

open access: yes, 2005
The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 ...
Fiocchi, A   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy